NATIONAL PHARMACEUTICAL DISTRIBUTOR OF UKRAINE

achievements company in numbers

  • 0

    years on the market

  • 0

    branches
    (in 24 regions)

  • 0

    regular customers

  • 0

    delivery points

  • 0

    product names

  • 0

    suppliers

  • 0

    total warehouse area

  • 0

    orders per day

interesting news

Programs Social projects
  • TOGETHER Program (ABBOTT CARDS) from ABBOTT PRODUCTS OPERATIONS

     

    the company is focused on the key needs in healthcare, the development of new medicines, technologies and treatments. This is an international diversified company operating in the health sector. Time-tested products are highly appreciated by experts worldwide for its efficiency, reliability and safety. Program Time (ABBOTT CARDS ) provides the opportunity to purchase efficient medications at a more affordable price.

    Drugs project:


    Heptral since.lyophil.d/R-RA d/INF.500mg FL., No. The 5+solution.amp.5ml No. 5
    Heptral tab.enteric solution.500 mg No. 20

    More details about conditions of participation in the project can be found on the project website Abbott cards

     

    More details >>
  • ORANGE CARD program from GlaxoSmithKline Pharmaceuticals

     

    Program of Access to medicines “Orange Card” was organized by GlaxoSmithKline Pharmaceuticals LLC in 2001. In 2003, the initiative “Orange Card” of GlaxoSmithKline Pharmaceuticals LLC was awarded “Corporate Social Responsibility in the USA” award, and soon after, it turned into a large-scale project “GSK For You” and “TogetherRx”, with the membership of 18 multinational pharmaceutical companies. Long-term Program “Orange Card” is the implementation of the global mission of GlaxoSmithKline Pharmaceuticals LLC, that is to provide people with more opportunities to feel better and live longer. LLC “Venta LTD” supports the social initiative of GlaxoSmithKline Pharmaceuticals to provide the population of Ukraine with high quality medicines at affordable prices.

    Drugs project:

    seretide Evohaler the Aer.25мкг/50mcg 120d
    Seretide Evohaler the Aer.25мкг/125мкг 120d
    Seretide Discus since.d/ing.50/60D 500мкг
    Seretide Evohaler the Aer.25мкг/250мкг 120d
    Seretide Discus since.d/ing.50/60D 250мкг
    Seretide Discus since.d/ing.50/100mcg 60D

    More details about conditions of participation in the project can be found on the project website ORANGE CARD . 

     

    More details >>
  • Health Value Program

     

     

    the goal of the programme “Value for health” – support of patients in long-term care By encouraging the development of safe and affordable medicine. During the program the patient has s the opportunity to get drugs at a discount.

     

    Gardens table.p/p/about 10mg №30
    Singani table.p/p/o 12.5 mg/1000mg No. 60
    Spiriva since.d/ing.in the caps.18мкг No. 30
    Spiriva respimat of R-R d/ing.2.5 µg/ing.4ml 60доз
    Pradaxa caps.TV.110мг No. 60
    Pradaxa caps.TV.150mg no 60

    More details about conditions of participation in the project can be found on https://medicard.com.ua/medicard/page/programms/

     

    More details >>
  • Therapy PLUS program from Astra Zeneca

     

    “PLUS Therapy” – the program aims to support patients with chronic diseases in areas such as cardiology, endocrinology, pneumology, psychiatry and Oncology. For each Drug, which participates in the Program, define an appropriate charging scheme discounts. The discount is given to cardholders ‘Terapias”, which are issued to patients who had been prescribed the drug involved in the Program “Terapias”, by a doctor of the healthcare institution.

    Drugs project:

    Atacand table.16my No. 28
    Atacand table.8mg No. 28
    Brilinta table. p/o 90my No. 56
    Combogia XR table.p/p/o of 2.5 mg/1000mg No. 28
    Combogia XR table.n/a n/a 5mg/1000mg No. 28
    Crestor tabl.n/a 10mg number 28
    Crestor tabl.n/a 20 n 28
    Crestor tabl.p/p/o 40mg No. 28
    Crestor tabl.n/a 5 mg №28
    Onglyza table.p/p/2.5 mg No. 30
    Onglyza table.p/p/o 5 mg number 30
    Symbicort Turbuhaler since.d/ing.160мкг/4.5 mcg/d. 60D
    Symbicort Turbuhaler since.d/ing.320мкг/9.0 µg/d. 60D
    Symbicort Turbuhaler since.d/ing.80мкг/4.5 mcg/d. 60D
    FixYa table.p/p/about 10mg №30
    Xiguo Prolong table.p/p/prolong.actions.10/1000mg No. 28
    Xiguo Prolong table.p/p/prolong.actions.5/1000mg No. 28

    More details about conditions of participation in the project can be found on the project website Therapy PLUS

     

    More details >>
  • Program "Map of Hope"

     

    “the MAP of hope” – program to SUPPORT patients  in areas such as gynecology and Oncology.

     

     

    Drugs project:

    Zoladex caps.d/the subcutan.intr.3.6 mg syringe applic no.1
    The Zoladex caps.d/the subcutan.intr.10.8 mg syringe applic no.1
    Faslodex-R-R d/in.250mg/5ml syringe 5ml No. 2
    Magrisso table.p/p/on 80 mg number 30
    Limpeza caps.TV.50mg n448

    More details about conditions of participation in the project can be found on https://medicard.com.ua/medicard/page/programms/

     

    More details >>
  • Program "For Life"

     

    the Program «For life” – this discount program which is organized by the company «Pfizer Export Bi.VI.”.
    The aim of the Programme – make the drug company Pfizer participating in the Program and prescribed by the attending physician, more accessible to all patients.

    Drugs project:

    Sutent caps.12.5 mg # 28
    Sutent caps.25mg no 28
    Sutent caps.50mg no 28
    Ibras caps.100mg №21
    Ibras caps.125мг No. 21
    Ibras caps.75mg №21
    Calcari caps.200mg blister No. 60
    Calcari caps.250mg no 60
    Inlet table.p/p/about 1 mg №56
    Inlet table.p/p/o 5 mg №56

    More details about conditions of participation in the project can be found on https:http://www.pfizermed.com.ua/public/zarady-zhittya

     

    More details >>
  • Protect Vessels - Save the Heart Program

     

    we invite You to join the ‘Protect the vessels – save heart”, which is designed to increase the availability of treatment and quality medicines and aims to make the prevention and treatment of cardiovascular diseases more effectively.

    Drugs project:

    Atoris, table. n/sq. about. 10mg N30 (10х3)
    Atoris, table. n/sq. about. 10mg N90 (10х9)
    Atoris, table. n/sq. about. 20mg N30 (10х3)
    Atoris, table. n/sq. about. 20mg N90 (10х9)
    Atoris, table. n/sq. about. 40mg N30 (10х3)
    Atoris, table. n/sq. about. 40mg N90 (10х9)

    Koriol table. 3,125 mg №28 (7x4)
    Koriol table. 6.25 mg No. 28 (7x4)
    Koriol table. 12.5 mg №28 (7x4)
    Koriol table. 25 mg No. 28 (7x4)

     read More about conditions of participation in the project can be found the project website to support patients “Protect blood vessels – save heart”

     

    More details >>
  • Let's Save Health Together

     

    The program “Let’s Keep Healthy Together” is aimed at supporting patients with chronic diseases related to such branches as: gynecology, urology, surgery, therapy, oncology and others.
    The main goal of the program “Let’s Keep Healthy Together” is to increase patient adherence to prescribed therapy by:

    Drugs project:


    • raising awareness of patients about the disease;
    • reducing the cost of therapy.

     

     

    More details >>

Suppliers global partnership

AUSTRALIA USA SOUTH AMERICA EGYPT ISRAEL     SNG CHINA JAPAN COUNTRIES EUROPEAN UNION Austria Belgium Bulgaria Hungary Germany Georgia Denmark Ireland Spain Italy Cyprus Latvia Lithuania Malta Netherlands Poland Portugal Romania Slovakia Slovenia Finland France Croatia Czech Sweden Estonia COUNTRIES EUROPEAN UNION Austria Belgium Bulgaria Hungary Germany Georgia Denmark Ireland Spain Italy Cyprus Latvia Lithuania Malta Netherlands Poland Portugal Romania Slovakia Slovenia Finland France Croatia Czech Sweden Estonia COUNTRIES EUROPEAN UNION Austria Belgium Bulgaria Hungary Germany Georgia Denmark Ireland Spain Italy Cyprus Latvia Lithuania Malta Netherlands Poland Portugal Romania Slovakia Slovenia Finland France Croatia Czech Sweden Estonia CANADA INDIA
  •  

    Darnitsa is a pharmaceutical company, a leader in Ukrainian market in the production and physical sales of prescription (Rx) and over-the-counter (OTC) generic products. The company began operating in 1930. In 2019, Darnitsa rebranded and announced a new business strategy: to transform based on digital technologies, to build an international brand and to lead in the generic segment of medicines.
    The company's portfolio includes 280 names of ready-to-use drugs. Darnitsa focuses on the treatment of cardiac, neurological diseases and pain. Its products are exported to 16 countries.
    The Darnitsa plant in Kyiv has 14 production lines certified according to the GMP standard.

    https://www.darnitsa.ua/

     

  • Farmak is the leader of pharmaceutical market with a share of 5.9 %. The medicines of all fourteen therapeutic groups are produced at the factory. Among the main areas are anti-cold, endocrinological, gastroenterological, cardiological and neurological portfolios. Every year, Farmak launches approximately 20 new drugs on the market; these are complex modern medications needed by millions of people, both in our country and abroad. About a hundred drugs are currently under development.

    www.farmak.ua

  •  

    Orion is a globally operating Finnish pharmaceutical company - a builder of well-being. Orion develops, manufactures and markets human pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology, respiratory diseases.
    Orion's main market is Finland, where it is the clear market leader. Orion’s products are marketed in over a hundred countries, and the Group's own human pharmaceuticals sales organization covers almost all key European markets and a few Southeast Asian countries. In other markets Orion’s products are sold by several collaboration partners. All of Orion's manufacturing plants and most of its R&D operations are in Finland. Orion’s headquarters are in Espoo.

     

    http://orionpharma.com.ua/

  • «Perrigo is a world leading health company which creates and provides non-prescription (ОТС) and perscription (Rx) medicines, consumer goods, food products and  active pharmaceutical ingredients (API). Since 1887, Perrigo has been providing its customers and consumers with high-quality products that support personal health and wellness by delivering effective solutions that meet the needs of consumers almost all over the world – mostly in Northern America, Europe, Australia, and other key markets like Israel and China».

    https://perrigo.ua/

  • the Company RECORDED GROUPS, with headquarters in Milan (Italy), has offices in many countries of Central and Eastern Europe, in Russia, in Turkey, in North Africa and in the United States of America.

    http://www.recordati.com.ua/article/view_article.php?id=4